Marshall Wace North America’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,182	Closed	-$174K	–	951
2018 Q2	$174K	Sell	1,182 -2,906	-71%	-$428K	﹤0.01%	1286
2018 Q1	$670K	Buy	+4,088	New	+$670K	﹤0.01%	1094